ETHOS TECHNOLOGIES INC CL-A (LIFE) Forecast, Price Target & Analyst Ratings

NASDAQ:LIFE • US29765A1016

Current stock price

13.88 USD
+0.93 (+7.18%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ETHOS TECHNOLOGIES INC CL-A (LIFE).

Forecast Snapshot

Consensus Price Target

Price Target
$21.57
+ 55.37% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$1.00
Revenue Estimate
147.94M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.57
Upside
+ 55.37%
From current price of $13.88 to mean target of $21.57, Based on 15 analyst forecasts
Low
$16.16
Median
$20.40
High
$32.55

Price Target Revisions

1 Month
-14.05%
3 Months
-14.05%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for LIFE. The average price target is 21.57 USD. This implies a price increase of 55.37% is expected in the next year compared to the current price of 13.88.
The average price target has been revised downward by 14.05% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LIFE Current Analyst RatingLIFE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

LIFE Historical Analyst RatingsLIFE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
LIFE was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LIFE.
In the previous month the buy percentage consensus was at a similar level.
LIFE was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-26CitigroupMaintains Buy -> Buy
2026-02-24Deutsche BankInitiate Buy
2026-02-23CitizensInitiate Market Outperform
2026-02-23William BlairInitiate Outperform
2026-02-23BarclaysInitiate Overweight
2026-02-23JP MorganInitiate Overweight
2026-02-23BairdInitiate Outperform
2026-02-23Goldman SachsInitiate Buy
2026-02-23B of A SecuritiesInitiate Buy
2026-02-23CitigroupInitiate Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-15RBC CapitalMaintains Outperform -> Outperform
2024-03-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-21HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-21HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-10HC Wainwright & Co.Reiterate Buy -> Buy
2023-07-21Piper SandlerMaintains Overweight -> Overweight
2023-07-05OppenheimerDowngrade Outperform -> Perform
2023-05-23HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-10RBC CapitalReiterate Outperform
2023-04-11Piper SandlerMaintains Overweight
2023-03-10RBC CapitalReiterate Outperform
2023-03-10HC Wainwright & Co.Reiterate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$1.00
Revenue Estimate
147.94M
Revenue Q2Q
55.73%
EPS Q2Q
-291.85%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
LIFE revenue by date.LIFE revenue by date.
353K
-96.60%		255M
72,137.96%		388M
52.16%		523.26M
34.86%		644.68M
23.20%		754.68M
17.06%		527.66M
-30.08%		753.26M
42.75%		990.03M
31.43%
EBITDA
YoY % growth
LIFE ebitda by date.LIFE ebitda by date.
-54.327M
-17.66%		54.44M
200.21%		78.36M
43.94%		103.24M
31.75%		138.59M
34.24%		174.98M
26.26%		171.26M
-2.13%		281.52M
64.38%		395.76M
40.58%
EBIT
YoY % growth
LIFE ebit by date.LIFE ebit by date.
-54.919M
-18.35%		49M
189.22%		73M
48.98%		-113.57M
-255.57%		53.154M
146.80%		96.246M
81.07%		352.81M
266.57%		549.58M
55.77%		799.19M
45.42%
Operating Margin
LIFE operating margin by date.LIFE operating margin by date.
-15,557.79%19.22%18.81%-21.70%8.25%12.75%66.86%72.96%80.72%
EPS
YoY % growth
LIFE eps by date.LIFE eps by date.
-0.96
40.00%		N/A
2.52%		N/A
248.01%		-0.16
-111.37%		1.29
918.39%		2.39
85.50%		4.01
67.88%		6.41
59.72%		8.69
35.56%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-1.00
-291.85%		0.21
178.27%		0.24
-13.36%		0.29
-30.06%		0.75
175.54%		0.45
118.67%		0.46
89.57%		0.49
66.67%
Revenue
Q2Q % growth		147.94M
55.73%		116.22M
30.58%		121.07M
28.80%		137.78M
25.17%		194.91M
31.75%		143.2M
23.21%		144.42M
19.29%		157.79M
14.52%
EBITDA
Q2Q % growth		32.057M20.278M
-6.72%		23.191M
10.01%		28.013M
-4.59%		50.194M
56.58%		28.198M
39.06%		29.101M
25.48%		31.105M
11.04%
EBIT
Q2Q % growth		-128.641M
-1,089.55%		4.933M
-74.04%		8.066M
-52.55%		13.859M
-42.25%		48.45M
137.66%		26.724M
441.74%		27.948M
246.49%		29.58M
113.44%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LIFE Yearly Revenue VS EstimatesLIFE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
LIFE Yearly EPS VS EstimatesLIFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -50 -100 -150

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.45%
EPS Next 5 Year
35.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
976.00%
Revenue Next 5 Year
347.61%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
70.44%
EBIT Next 5 Year
46.50%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ETHOS TECHNOLOGIES INC CL-A / LIFE Forecast FAQ

What is the average price target for ETHOS TECHNOLOGIES INC CL-A (LIFE) stock?

15 analysts have analysed LIFE and the average price target is 21.57 USD. This implies a price increase of 55.37% is expected in the next year compared to the current price of 13.88.

Can you provide the consensus estimates for ETHOS TECHNOLOGIES INC CL-A next earnings?

The consensus EPS estimate for the next earnings of ETHOS TECHNOLOGIES INC CL-A (LIFE) is -1 USD and the consensus revenue estimate is 147.94M USD.

Can you provide the analyst count for ETHOS TECHNOLOGIES INC CL-A stock?

The number of analysts covering ETHOS TECHNOLOGIES INC CL-A (LIFE) is 15.